Novartis has finally given up on iscalimab after deciding that the anti-CD40 antibody is not worth pursuing in Sjögren’s syndrome. On a fourth-quarter earnings call with the media this morning ...

Find effective medications for 'Sjogren's Syndrome treatment right here!' This page is a trusted source for both professionals and patients, detailing brand-name and generic options designed to ...

The following is a summary of “Prevalence, clinical features, and long-term outcome of patients with primary Sjögren’s ...

The rheumatologist may then suggest an Anti-Nuclear-Antibody test. If the ANA test is positive and the dryness is clinically significant, the diagnosis of Sjogren’s syndrome is confirmed.

Recent decades have witnessed remarkable strides in the realm of clinical research and treatment for Systemic Lupus Erythematosus (SLE) and Sjögren’s ...

Muscarinic agonists are most popular drugs for Sjögren's syndrome. Other drugs including IFN-α, anti-TNF-α or B-cell targeted therapy are considered but efficacy is not confirmed yet.

Sjogren’s syndrome (SS) is an autoimmune condition ... including the development of abnormal antibodies—anti-SSA and anti-SSB—which are usually present in SS and rheumatic diseases.

Johnson & Johnson’s ‘Swiss army knife’ for autoimmune diseases – FcRn inhibitor nipocalimab – has shown efficacy in Sjogren’s disease ... It is one of a pack of anti-FcRn drugs ...

Learn more about Sjögren's (SHOW-grins) syndrome at the inaugural Sjögren's Syndrome Conference at Baylor College of Medicine Oct. 27. The conference will be held at the Lee and Joe Jamail Specialty ...